These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10649502)

  • 21. The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy.
    Miller JN; Kovács AD; Pearce DA
    Hum Mol Genet; 2015 Jan; 24(1):185-96. PubMed ID: 25205113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From locus to cellular disturbances: positional cloning of the infantile neuronal ceroid lipofuscinosis gene.
    Hellsten E; Vesa J; Jalanko A; Peltonen L
    Neuropediatrics; 1997 Feb; 28(1):9-11. PubMed ID: 9151310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency.
    Kälviäinen R; Eriksson K; Losekoot M; Sorri I; Harvima I; Santavuori P; Järvelä I; Autti T; Vanninen R; Salmenperä T; van Diggelen OP
    Eur J Neurol; 2007 Apr; 14(4):369-72. PubMed ID: 17388982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis.
    Savukoski M; Klockars T; Holmberg V; Santavuori P; Lander ES; Peltonen L
    Nat Genet; 1998 Jul; 19(3):286-8. PubMed ID: 9662406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy.
    Ranta S; Topcu M; Tegelberg S; Tan H; Ustübütün A; Saatci I; Dufke A; Enders H; Pohl K; Alembik Y; Mitchell WA; Mole SE; Lehesjoki AE
    Hum Mutat; 2004 Apr; 23(4):300-5. PubMed ID: 15024724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Two novel mutations in palmitoyl-protein thioesterase gene in two Chinese babies with infantile neuronal ceroid lipofuscinosis].
    Bi HY; Yao S; Bu DF; Wang ZX; Zhang Y; Qin J; Yang YL; Yuan Y
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):496-9. PubMed ID: 17044973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons.
    Jalanko A; Vesa J; Manninen T; von Schantz C; Minye H; Fabritius AL; Salonen T; Rapola J; Gentile M; Kopra O; Peltonen L
    Neurobiol Dis; 2005 Feb; 18(1):226-41. PubMed ID: 15649713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL.
    Xin W; Mullen TE; Kiely R; Min J; Feng X; Cao Y; O'Malley L; Shen Y; Chu-Shore C; Mole SE; Goebel HH; Sims K
    Neurology; 2010 Feb; 74(7):565-71. PubMed ID: 20157158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel nonsense mutation (Q509X) in three Italian late-infantile neuronal ceroid-lipofuscinosis children.
    Tessa A; Simonati A; Tavoni A; Bertini E; Santorelli FM
    Hum Mutat; 2000 Jun; 15(6):577. PubMed ID: 10862088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational and structural investigation of Palmitoyl-Protein Thioesterase 1 (PPT1) protein causing Neuronal Ceroid Lipofuscinoses (NCL).
    Thirumal Kumar D; Shaikh N; Udhaya Kumar S; George Priya Doss C
    Adv Protein Chem Struct Biol; 2022; 132():89-109. PubMed ID: 36088080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant late infantile neuronal ceroid lipofuscinosis because of CLN1 mutations.
    Simonati A; Tessa A; Bernardina BD; Biancheri R; Veneselli E; Tozzi G; Bonsignore M; Grosso S; Piemonte F; Santorelli FM
    Pediatr Neurol; 2009 Apr; 40(4):271-6. PubMed ID: 19302939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and molecular analysis of Japanese patients with neuronal ceroid lipofuscinosis.
    Oishi K; Ida H; Kurosawa K; Eto Y
    Mol Genet Metab; 1999 Apr; 66(4):344-8. PubMed ID: 10191127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA diagnosis and identification of carriers of infantile and juvenile neuronal ceroid lipofuscinoses.
    Syvänen AC; Järvelä I; Paunio T; Vesa J
    Neuropediatrics; 1997 Feb; 28(1):63-6. PubMed ID: 9151326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis.
    Bellizzi JJ; Widom J; Kemp C; Lu JY; Das AK; Hofmann SL; Clardy J
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4573-8. PubMed ID: 10781062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro depalmitoylation of neurospecific peptides: implication for infantile neuronal ceroid lipofuscinosis.
    Cho S; Dawson PE; Dawson G
    J Neurosci Res; 2000 Jan; 59(1):32-8. PubMed ID: 10658183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset.
    Pineda-Trujillo N; Cornejo W; Carrizosa J; Wheeler RB; Múnera S; Valencia A; Agudelo-Arango J; Cogollo A; Anderson G; Bedoya G; Mole SE; Ruíz-Linares A
    Neurology; 2005 Feb; 64(4):740-2. PubMed ID: 15728307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variant late infantile ceroid lipofuscinoses associated with novel mutations in CLN6.
    Cannelli N; Garavaglia B; Simonati A; Aiello C; Barzaghi C; Pezzini F; Cilio MR; Biancheri R; Morbin M; Dalla Bernardina B; Granata T; Tessa A; Invernizzi F; Pessagno A; Boldrini R; Zibordi F; Grazian L; Claps D; Carrozzo R; Mole SE; Nardocci N; Santorelli FM
    Biochem Biophys Res Commun; 2009 Feb; 379(4):892-7. PubMed ID: 19135028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland.
    Moore SJ; Buckley DJ; MacMillan A; Marshall HD; Steele L; Ray PN; Nawaz Z; Baskin B; Frecker M; Carr SM; Ives E; Parfrey PS
    Clin Genet; 2008 Sep; 74(3):213-22. PubMed ID: 18684116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients.
    Sheth J; Mistri M; Bhavsar R; Pancholi D; Kamate M; Gupta N; Kabra M; Mehta S; Nampoothiri S; Thakker A; Jain V; Shah R; Sheth F
    BMC Neurol; 2018 Dec; 18(1):203. PubMed ID: 30541466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.
    Worgall S; Kekatpure MV; Heier L; Ballon D; Dyke JP; Shungu D; Mao X; Kosofsky B; Kaplitt MG; Souweidane MM; Sondhi D; Hackett NR; Hollmann C; Crystal RG
    Neurology; 2007 Aug; 69(6):521-35. PubMed ID: 17679671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.